Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
6.95
+1.46 (26.59%)
At close: Nov 6, 2026, 4:00 PM EST
7.17
+0.22 (3.17%)
After-hours: Nov 6, 2026, 7:59 PM EST
Onconetix Market Cap
Onconetix has a market cap or net worth of $2.74 million as of November 6, 2026. It is the 46,979th most valuable company in the world and the 6,233rd biggest in the United States. Its market cap has decreased by 41.77% in one year.
Market Cap
2.74M
Enterprise Value
-3.01M
1-Year Change
-41.77%
Global Rank
Country Rank
#6,233 United States
Category
ChartMarket Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $585.52M to $2.74M, a decrease of -99.53%. That is a compound annual growth rate of -67.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 2.74M | 13.14% |
| Dec 31, 2025 | 2.43M | -53.54% |
| Dec 31, 2024 | 5.22M | 41.00% |
| Dec 29, 2023 | 3.70M | -78.00% |
| Dec 30, 2022 | 16.83M | -97.13% |
| Feb 18, 2022 | 585.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eocene | 2.93M |
| Calidi Biotherapeutics | 2.93M |
| HCW Biologics | 2.53M |
| NeuroSense Therapeutics | 2.52M |
| Clearmind Medicine | 2.52M |
| Revelation Biosciences | 2.49M |
| VivoSim Labs | 2.48M |
| Karyopharm Therapeutics | 2.10M |